Publicaciones en las que colabora con EDUARDO DÍAZ-RUBIO GARCÍA (11)

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

2005

  1. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2002

  1. Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262

  2. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  3. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors

    Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860

1998

  1. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer

    Oncology, Vol. 55, Núm. 3, pp. 249-257

1997

  1. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer

    British Journal of Cancer, Vol. 76, Núm. 1, pp. 44-51

1996

  1. Association of K-ras codon 12 transversions with short survival in non-small cell lung cancer

    International Journal of Oncology, Vol. 9, Núm. 6, pp. 1307-1311

1995

  1. Prevalence of p53 overexpression or mutations, but not K-ras mutations, in recurrent patients affected by colorectal carcinoma

    International Journal of Oncology, Vol. 7, Núm. 6, pp. 1319-1325